SCHEMBL8874004

SCHEMBL8874004

C[C@H](CNCCNC[C@@H](C)N)N1C(=O)c2cccc3cc([N+](=O)[O-])cc(c23)C1=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FTO Q9C0B1 2/20 0.56
▸ NTRK1 P04629 1/20 0.53
▸ NGFR P08138 1/20 0.53
▸ PABPC1 P11940 2/20 0.51
▸ CA12 O43570 3/20 0.48
▸ CA1 P00915 3/20 0.48
▸ CA2 P00918 3/20 0.48
▸ CA9 Q16790 3/20 0.48
▸ MEN1 O00255 6/20 0.48
▸ KMT2A Q03164 6/20 0.48
▸ POLB P06746 5/20 0.48
▸ MAPT P10636 3/20 0.48
▸ KDM4E B2RXH2 2/20 0.48
▸ S1PR1 P21453 1/20 0.48
▸ HTT P42858 1/20 0.48
▸ RAD52 P43351 1/20 0.48
▸ RECQL P46063 1/20 0.48
▸ RAB9A P51151 1/20 0.48
▸ PAX8 Q06710 1/20 0.48
▸ TDP1 Q9NUW8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9188871 1.00 FTO (0.56) FTONTRK1NGFRPABPC1CA12
Bisnafide SCHEMBL29617562 0.95 FTO (0.61) FTONTRK1NGFRPABPC1CA12
Bisnafide SCHEMBL9136683 0.95 FTO (0.61) FTONTRK1NGFRPABPC1CA12
Bisnafide SCHEMBL9136305 0.95 FTO (0.61) FTONTRK1NGFRPABPC1CA12
Bisnafide SCHEMBL9135370 0.95 FTO (0.61) FTONTRK1NGFRPABPC1CA12
Bisnafide SCHEMBL9135739 0.95 FTO (0.61) FTONTRK1NGFRPABPC1CA12
SCHEMBL9352511 0.94 FTO (0.60) FTONTRK1NGFRPABPC1CA12
SCHEMBL9348633 0.94 FTO (0.60) FTONTRK1NGFRPABPC1CA12
SCHEMBL9238619 0.94 FTO (0.60) FTONTRK1NGFRPABPC1CA12
SCHEMBL9352242 0.94 FTO (0.60) FTONTRK1NGFRPABPC1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5641782-A ANTITUMOR AGENTS THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1997-06-24 — — US disclosed
US-5585382-A ANTICARCINOGENIC AGENTS THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1996-12-17 — — US disclosed
US-5416089-A Antitumor agent THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1995-05-16 — — US disclosed
Send feedback